CClinicalTrials.gg
CompletedNCT07448792EUKINESUpdated Mar 4, 2026

EUKINES Wearable Plantar-Pressure Insole System for Rehabilitation After Total Hip Arthroplasty

An interventional study of Certified reference gait-analysis system and EUKINES plantar-pressure insole system in Hip Osteoarthritis, Total Hip Arthroplasty (THA) and Postoperative Rehabilitation, sponsored by Cardinal Stefan Wyszynski University. Completed at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Cardinal Stefan Wyszynski University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Dec 2024, registered Feb 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates a wearable plantar-pressure insole system (EUKINES) designed to support gait training during postoperative rehabilitation after primary total hip arthroplasty (THA). The trial will include 200 adults who are randomly assigned to one of four rehabilitation programs: EUKINES with real-time biofeedback, EUKINES without biofeedback, a certified commercial reference system with biofeedback, or standard rehabilitation without any gait-analysis device. All participants will receive a structured 6-week rehabilitation program after THA, and the only differences between groups concern the use of gait-analysis technology and biofeedback. The main outcomes include changes in plantar-pressure-based gait parameters (mean foot pressure and load asymmetry) and standard clinical scores of hip function and symptoms. The study will also monitor safety, device-related events, walking speed, pain, and patient and therapist ratings of usability and satisfaction. The goal is to determine whether rehabilitation supported by the EUKINES insole system is at least as effective and safe as rehabilitation supported by a certified reference system and as standard care, and to explore the feasibility of using low-cost, printed-sensor technology for routine gait assessment and future telerehabilitation.

Read the detailed description

This is a prospective, randomized, partially blinded, multicenter clinical trial with a non-inferiority design conducted in patients undergoing primary total hip arthroplasty (THA) for advanced osteoarthritis. The study is embedded in the EUKINES project, which develops low-cost, printable pressure sensors and a wearable plantar-pressure insole system intended for scalable clinical rehabilitation and telerehabilitation use. The trial evaluates the clinical performance, safety, and usability of the EUKINES insole system as an adjunct to standard postoperative rehabilitation.

Adult patients scheduled for primary THA will be screened according to predefined inclusion and exclusion criteria and enrolled after providing written informed consent. A total of 200 participants will be randomized in blocks to one of four parallel rehabilitation arms: (1) EUKINES with real-time biofeedback, (2) EUKINES without biofeedback (data recording only), (3) a certified commercial reference gait-analysis system with biofeedback, or (4) standard rehabilitation without any gait-analysis device. All participants will follow the same structured 6-week rehabilitation program after surgery, including routine physiotherapy and six additional, approximately 3-hour gait-focused sessions. The content and duration of rehabilitation are equivalent across groups; only the use of gait-analysis devices and biofeedback differs between arms.

Outcome assessments will be performed at baseline and during postoperative follow-up. Primary endpoints include changes in plantar-pressure-derived gait parameters such as mean foot pressure and load asymmetry between the operated and non-operated limb, as well as changes in hip-related clinical scores (Harris Hip Score and the 12-item Hip Disability and Osteoarthritis Outcome Score, HOOS-12) and the incidence of adverse events and device-related complications. Secondary outcomes include extended spatiotemporal gait parameters, 10-Meter Walk Test performance, pain intensity and satisfaction with surgery and rehabilitation, and patient and therapist ratings of usability, comfort, and perceived usefulness of the EUKINES and reference systems. All plantar-pressure time-series data will be stored to allow post-hoc derivation of additional gait metrics and exploratory analyses.

The study is classified as a low-risk, add-on interventional trial that does not alter standard surgical procedures or baseline postoperative care. Device-assisted rehabilitation sessions are provided as an adjunct to routine practice. The trial is conducted in accordance with the Declaration of Helsinki and Good Clinical Practice, under the oversight of a bioethics committee. By directly comparing the EUKINES prototype with a certified commercial reference system and standard care, the study aims to demonstrate the feasibility and clinical usefulness of an affordable sensor-based gait-analysis platform and to provide a basis for future development of data-driven telerehabilitation and personalized rehabilitation strategies.

02

Conditions studied

  • Hip Osteoarthritis
  • Total Hip Arthroplasty (THA)
  • Postoperative Rehabilitation

Browse trials for

Keywords

  • gait analysis
  • rehabilitation
  • plantar-pressure insoles
  • wearable sensors
  • printed sensors
  • biofeedback
  • telerehabilitation
  • total hip arthroplasty
  • mean foot pressure
  • EUKINES
03

In context

Osteoarthritis, Hip

628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.

This study's enrollment of 200 is above the median of 90 across 450 interventional studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

Cardinal Stefan Wyszynski University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 years or older.
  • Scheduled for primary total hip arthroplasty performed for advanced osteoarthritis or other degenerative hip disease.
  • Willingness and ability to participate in the 6-week postoperative rehabilitation program and follow-up assessments.
  • Ability to understand study information and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Coexisting medical conditions that may significantly affect rehabilitation outcomes or gait (e.g., severe neurological disorders, major lower-limb joint trauma, other significant musculoskeletal pathology).
  • Cognitive impairment or psychiatric conditions that would preclude effective cooperation with the rehabilitation and research team.
  • Any contraindication to participation in additional gait training sessions or use of the insole-based gait-analysis systems as judged by the treating physician.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    EUKINES with biofeedback

    Participants receive the structured postoperative rehabilitation program supported by the EUKINES plantar-pressure insole system with real-time biofeedback on gait parameters during the additional rehabilitation sessions.

    Device: EUKINES plantar-pressure insole system · Other: Structured postoperative rehabilitation program

  • Experimental
    EUKINES without biofeedback

    Participants receive the structured postoperative rehabilitation program while wearing the EUKINES plantar-pressure insole system without real-time biofeedback; gait data are recorded for analysis only during the additional rehabilitation sessions.

    Device: EUKINES plantar-pressure insole system · Other: Structured postoperative rehabilitation program

  • Active comparator
    Reference system with biofeedback

    Participants receive the structured postoperative rehabilitation program supported by a certified commercial plantar-pressure gait-analysis system providing real-time biofeedback on gait parameters during the additional rehabilitation sessions.

    Device: Certified reference gait-analysis system · Other: Structured postoperative rehabilitation program

  • Active comparator
    Standard rehabilitation

    Participants receive the same structured postoperative rehabilitation program without any gait-analysis device or biofeedback; rehabilitation is based on standard clinical practice at participating centers.

    Other: Structured postoperative rehabilitation program

Interventions

  • DeviceCertified reference gait-analysis system

    Commercially available, certified plantar-pressure gait-analysis system used according to the manufacturer's recommendations to provide real-time biofeedback on gait parameters during rehabilitation sessions.

  • DeviceEUKINES plantar-pressure insole system

    Wearable plantar-pressure insole system developed within the EUKINES project, consisting of thin-film printed pressure sensors, shoe-mounted electronic modules, and PC-based software for real-time gait data acquisition and visualization. In the biofeedback arm, real-time feedback on gait parameters is provided during rehabilitation sessions; in the non-biofeedback arm, data are recorded without feedback.

  • OtherStructured postoperative rehabilitation program

    Standard postoperative rehabilitation program after total hip arthroplasty, delivered according to local clinical protocols and including six additional approximately 3-hour gait-focused rehabilitation sessions over 6 weeks, with progressive gait training, balance and coordination exercises, and functional mobility tasks.

06

What researchers measure

Primary outcomes

  1. Change in mean foot pressure (MFP) on the operated limb

    Mean foot pressure (MFP) is defined as the average plantar pressure across all active sensing regions of the insole during the stance phase of gait, expressed in kilopascals. MFP will be recorded during standardized 10-meter walking trials using the EUKINES and/or reference insole systems, and session-level MFP will be calculated as the mean value across all valid steps. The primary analysis will compare changes in MFP on the operated limb over time and between rehabilitation arms.

    Time frame: Baseline (Week 0), Week 3, Week 6 after surgery

  2. Change in load asymmetry between operated and non-operated limb

    Load asymmetry will be quantified using plantar-pressure data from the EUKINES and/or reference insole systems as the difference or ratio between mean foot pressure on the operated and non-operated limb during standardized 10-meter walking trials. Reduced inter-limb asymmetry over time will be interpreted as improved functional load distribution after total hip arthroplasty.

    Time frame: Baseline (Week 0), Week 3, Week 6 after surgery

  3. Change in Harris Hip Score (HHS)

    The Harris Hip Score is a validated clinician-administered scale assessing pain, function, range of motion, and absence of deformity in patients after hip surgery. Total scores range from 0 to 100, with higher scores indicating better hip function. The primary analysis will compare changes in HHS from baseline to Week 6 between rehabilitation arms.

    Time frame: Baseline (preoperative or immediate postoperative) and Week 6 after surgery

  4. Change in HOOS-12 total score

    The HOOS-12 is a validated 12-item short form of the Hip Disability and Osteoarthritis Outcome Score that assesses pain, function, and quality of life in hip patients. Scores are transformed to a 0-100 scale, with higher scores indicating better outcomes. The main analysis will evaluate changes in HOOS-12 total score from baseline to Week 6, with reference to the minimal clinically important difference of approximately 9-12 points reported in the literature.

    Time frame: Baseline (preoperative or immediate postoperative) and Week 6 after surgery

  5. Incidence of adverse events and device-related complications

    Safety will be assessed by recording all adverse events, device-related complications, skin irritation, falls, or other medical incidents potentially associated with device use or the supplementary rehabilitation sessions. Events will be classified by severity, relationship to the device or intervention, and outcome.

    Time frame: From enrollment through Week 6 after surgery

Secondary outcomes

  1. Preferred walking speed (10-Meter Walk Test)

    Preferred walking speed over 10 meters will be measured in m/s during standardized 10-Meter Walk Tests; changes over time and between groups will be analyzed.

    Time frame: Baseline, Week 3, Week 6

  2. Change in maximal walking speed (10-Meter Walk Test)

    Maximal walking speed over 10 meters will be measured in m/s during standardized 10-Meter Walk Tests; changes over time and between groups will be analyzed.

    Time frame: Baseline, Week 3, Week 6

  3. Change in spatiotemporal gait parameters derived from plantar-pressure insoles

    Baseline, Week 3, Week 6

    Time frame: Additional gait parameters (e.g., cadence, stance and swing phase duration, rollover time) will be derived from plantar-pressure time-series data and analyzed as exploratory secondary outcomes.

  4. Change in hip pain intensity (VAS)

    Hip pain will be rated on a visual analogue scale (0-10), with higher scores indicating greater pain; changes over time and between groups will be compared.

    Time frame: Baseline, Week 3, Week 6

  5. Change in patient satisfaction with surgery and rehabilitation measured with a Visual Analogue Scale (VAS)

    Patient satisfaction with surgery and postoperative rehabilitation will be assessed using a 100-mm Visual Analogue Scale (VAS) ranging from 0 to 100, where 0 indicates "not satisfied at all" (worst possible satisfaction) and 100 indicates "extremely satisfied" (best possible satisfaction). The VAS score (points, 0-100; higher scores indicate better satisfaction) will be recorded at Week 3 and Week 6 after surgery, and changes over time and between study groups will be compared

    Time frame: Week 3 and Week 6

  6. Patient-reported usability and comfort of the EUKINES and reference systems (study-specific 15-item Likert-scale questionnaire)

    Patient-reported usability and comfort of the EUKINES system and the reference system will be assessed with a study-specific EUKINES Usability and Comfort Questionnaire developed by the investigators, consisting of 15 items rated on a 5-point Likert scale (0 = strongly disagree, 4 = strongly agree). For each system, an overall usability and comfort score will be calculated as the mean of all item scores and expressed in points (range 0-4; higher scores indicate better usability and greater comfort). Scores will be collected at Week 3 and Week 6 after surgery, and changes over time and between study groups will be compared.

    Time frame: Week 3 and Week 6

  7. Therapist-reported usability and perceived usefulness of the EUKINES and reference systems (study-specific 12-item Likert-scale questionnaire)

    Therapist-reported usability and perceived usefulness of the EUKINES system and the reference system will be assessed with a study-specific EUKINES Therapist Usability and Usefulness Questionnaire developed by the investigators, consisting of 12 items rated on a 5-point Likert scale (0 = strongly disagree, 4 = strongly agree). Two summary scores will be calculated for each system: a usability score and a perceived usefulness score, each expressed in points as the mean of the corresponding items (range 0-4; higher scores indicate better usability or greater perceived usefulness). Scores collected throughout the 6-week rehabilitation period will be analyzed as repeated measures and compared between systems and between study groups.

    Time frame: Throughout the 6-week rehabilitation period

07

Study locations

1 site
  • Cardinal Stefan Wyszynski University in Warsaw, Collegium Medicum - Affiliated Orthopaedic Department
    Warsaw, Masovian Voivodeship 01-938, Poland
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because there is no dedicated infrastructure or funding for long-term controlled access data sharing beyond the requirements for publication and regulatory reporting.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07448792
Lead sponsor
Cardinal Stefan Wyszynski University
Collaborators
National Center for Research and Development, Poland, Warsaw University of Technology
Responsible party
Sponsor
First posted
Mar 4, 2026
Start date
Dec 15, 2024
Primary completion
Nov 30, 2025
Completion
Nov 30, 2025
Last update
Mar 4, 2026

Study contacts

Andrzej Kotela
principal investigator · Cardinal Stefan Wyszynski University in Warsaw

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion